Is there role of Loading dose of antiplatelets in Stroke
Reading File
Finding Sources
Finding Sources
Searching PubMed
antiplatelet loading dose ischemic stroke
Reading File
Reading File
Reading File
Reading Article
PMID: 38157499
Reading File
Reading Article
PMID: 35028933
I now have rich data from multiple authoritative sources. Let me compile the comprehensive answer.
Loading Dose of Antiplatelets in Stroke
Why a Loading Dose?
Antiplatelet agents like clopidogrel and ticagrelor are prodrugs (clopidogrel) or require time to reach steady-state inhibition. A loading dose rapidly saturates platelet ADP receptors, achieving effective platelet inhibition within 4-6 hours - critical in the acute stroke setting where recurrence risk is highest in the first 24-48 hours. Without a loading dose, steady-state inhibition with clopidogrel 75 mg/day would take 5-7 days.
Clinical Context: Where Loading Doses Are Used
1. Acute Minor Ischemic Stroke and High-Risk TIA
This is the most evidence-supported indication. The rationale is dual antiplatelet therapy (DAPT) for the early high-risk period.
Clopidogrel + Aspirin (POINT and CHANCE trials framework):
As stated in Goldman-Cecil Medicine, for patients with high-risk TIA or a minor, nondisabling ischemic stroke:
"21 days of dual antiplatelet therapy with clopidogrel (600 mg loading dose on day 1, followed by 75 mg per day) plus aspirin (50-325 mg per day)... decreases the risk of recurrent stroke by ~30% compared with monotherapy, but increases the risk of major bleeding by about 40%."
- Goldman-Cecil Medicine, Stroke chapter
Ticagrelor + Aspirin (THALES trial framework):
Harrison's (22nd Edition) states:
"Ticagrelor, 180 mg loading dose and then 90 mg twice daily, was tested in combination with aspirin compared to aspirin alone, and this also showed benefit in preventing stroke; this dual antiplatelet regimen may be favored because of the lack of genetic heterogeneity in platelet inhibition."
- Harrison's Principles of Internal Medicine, 22e, TIA/Stroke chapter
This is important because clopidogrel requires CYP2C19 metabolism - up to 25% of whites, 30% of African Americans, and 50% of Asians carry loss-of-function CYP2C19 alleles, making them poor clopidogrel metabolizers. Ticagrelor bypasses this limitation. - Harrison's Principles, p. 987
2. The INSPIRES Trial (2023 - Extending the Time Window)
A landmark NEJM RCT (Gao et al., 2023) addressed whether DAPT works when initiated within 72 hours (not just 24 hours):
- N = 6,100 patients with mild ischemic stroke or high-risk TIA of atherosclerotic cause
- Clopidogrel 300 mg loading on Day 1, then 75 mg/day for 90 days + aspirin (Days 1-21)
- Result: New stroke at 90 days: 7.3% (DAPT) vs. 9.2% (aspirin alone), HR 0.79 (95% CI 0.66-0.94; P = 0.008)
- Bleeding: Moderate-to-severe bleeding 0.9% vs 0.4% (HR 2.08; higher but still low absolute risk)
- Conclusion: DAPT benefit extends up to 72 hours after onset in atherosclerotic stroke/TIA
Note: 87.2% of patients were enrolled 24-72 hours after onset - extending the actionable time window considerably.
3. Specific Loading Dose Regimens - Summary Table
| Drug | Loading Dose | Maintenance | Indication in Stroke |
|---|---|---|---|
| Aspirin | 160-325 mg (started within 48 h) | 75-100 mg/day | Any acute ischemic stroke (monotherapy if no DAPT) |
| Clopidogrel | 300-600 mg (Day 1) | 75 mg/day | Minor stroke/high-risk TIA (DAPT) |
| Ticagrelor | 180 mg (Day 1) | 90 mg twice daily | Minor stroke/high-risk TIA (DAPT, preferred if CYP2C19 uncertainty) |
| Prasugrel | 60 mg | 10 mg/day | Contraindicated in prior stroke/TIA (high bleeding risk) |
- Harrison's Principles, p. 987; Goldman-Cecil Medicine, Stroke chapter
Key Trials Supporting Loading Dose DAPT
| Trial | Regimen | Key Finding |
|---|---|---|
| CHANCE (China) | Clopidogrel 300 mg load + aspirin ≤24 h, 21 days | ~32% RRR in stroke at 90 days |
| POINT (USA/International) | Clopidogrel 600 mg load + aspirin ≤12 h, 90 days | ~25% RRR; higher bleeding with prolonged DAPT |
| THALES | Ticagrelor 180 mg load + aspirin ≤24 h, 30 days | ~17% RRR in stroke/death; preferred where CYP2C19 unknown |
| INSPIRES (2023) | Clopidogrel 300 mg load + aspirin ≤72 h, 90 days | ~14% RRR; extends time window to 72 h |
Duration of Dual Antiplatelet Therapy
The consensus from Harrison's 22e is:
"The combination of clopidogrel or ticagrelor plus aspirin for 21-30 days followed by aspirin alone thereafter reduces the risk of stroke, MI, and vascular death by up to 30%."
- Long-term DAPT (>30 days) is NOT recommended - it increases bleeding without proportionate stroke reduction (Goldman-Cecil Medicine).
- After 21-30 days: step down to aspirin monotherapy (75-100 mg/day) for long-term secondary prevention.
Important Caveats
-
Aspirin alone in major stroke: For patients with a major (not minor) ischemic stroke, aspirin 325 mg daily should be started within 24 hours. Loading DAPT is not recommended for major strokes due to hemorrhagic transformation risk.
-
Timing with thrombolytics: Aspirin should not be started within 24 hours of IV tPA unless benefits clearly outweigh bleeding risk.
-
No role for prasugrel: Prasugrel is contraindicated in prior stroke/TIA due to excess intracranial bleeding (Harrison's 22e, p. 987).
-
Anticoagulation: Urgent anticoagulation to prevent recurrent stroke is not recommended in the acute phase (Goldman-Cecil Medicine).
-
CYP2C19 polymorphism: If rapid access to genotyping is unavailable (most acute settings), ticagrelor may be preferred over clopidogrel for DAPT, particularly in Asian populations.
Bottom Line
Yes, loading doses of antiplatelets have a well-established role in stroke, specifically:
- In minor ischemic stroke and high-risk TIA, a loading dose of clopidogrel (300-600 mg) or ticagrelor (180 mg) combined with aspirin reduces 90-day recurrent stroke risk by ~14-32% when initiated within 24-72 hours of onset.
- The Cochrane systematic review (Minhas et al., 2022, PMID 35028933) confirms aspirin (160-300 mg) within 48 hours reduces death/dependency in any acute ischemic stroke.
- The INSPIRES RCT (2023, PMID 38157499) extends the DAPT benefit window to 72 hours for atherosclerotic minor stroke/TIA.
- DAPT should be limited to 21-30 days then stepped down to single antiplatelet to avoid excess bleeding.
This is a shared conversation. Sign in to Orris to start your own chat.